Proteinase inhibitor α1-antichymotrypsin has different expression in various forms of neuronal ceroid lipofuscinosis
- 1 October 1990
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 110 (1) , 121-126
- https://doi.org/10.1016/0014-4886(90)90056-x
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- α1-Antichymotrypsin is associated solely with amyloid deposits containing the β-protein. Amyloid and cell localization of α1-antichymotrypsinNeurobiology of Aging, 1990
- The amyloid precursor protein is concentrated in neuronal lysosomes in normal and Alzheimer disease subjectsExperimental Neurology, 1989
- Batten disease (Spielmeyer‐Sjogren disease) and haptoglobins (HP): indication of linkage and assignment to chr. 16Clinical Genetics, 1989
- Review Article: The Neuronal Ceroid LipofuscinosesJournal of Child Neurology, 1989
- Immunoreactivity of neuronal lipofuscin with monoclonal antibodies to the amyloid β-proteinNeurobiology of Aging, 1989
- Natural history of alpha-1-protease inhibitor deficiencyThe American Journal of Medicine, 1988
- Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's diseaseCell, 1988
- Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activityNature, 1988
- Immunohistochemical demonstration of proteinase inhibitor alpha-1-antichymotrypsin in normal human central nervous systemJournal of Cellular Biochemistry, 1987
- Inhibitors of Lysosomal Enzymes: Accumulation of Lipofuscin-Like Dense Bodies in the BrainScience, 1984